Abbott | ABT - Despesas Operacionais

Preço das Ações
111.68
Mudança Diária
1.73 1.57%
Mensal
-1.42%
Anual
-11.58%
Q1 Previsão
104.77




Despesas Operacionais Alterar Data
Abbott USD 9.21B 17M 2025-12
Agilent USD 1.44B 27M 2025-12
AtriCure USD 138.01M 3.95M 2025-12
Baxter International USD 3.19B 554.4M 2025-12
Becton, Dickinson and Co. USD 4.59B 476M 2025-12
Bio-Rad Laboratories USD 6.74B 6.16B 2025-09
Boston Scientific USD 4.04B 18M 2025-12
Cooper Companies USD 811.3M 113.5M 2025-12
Danaher USD 5.34B 45.74B 2025-12
Dexcom USD 936.6M 30.2M 2025-12
Edwards Lifesciences USD 1.2B 71.3M 2025-12
Globus Medical USD 645.11M 241.46M 2025-12
Hologic USD 349.4M 447.1M 2025-12
Insulet USD 637.5M 48.9M 2025-12
Integra LifeSciences USD 368.92M 668.65M 2025-12
Intuitive Surgical USD 2B 263.6M 2025-12
J&J USD 18.97B 2.38B 2025-12
Masimo USD 328.6M 181.6M 2025-12
Medtronic USD 7.28B 16M 2025-12
Merit Medical Systems USD 339.74M 1.8M 2025-12
Pfizer USD 12.91B 79.89B 2025-12
Smith & Nephew USD 2.52B 84M 2025-12
Solventum Corp USD 1.89B 3.09B 2025-12
Stryker USD 5.2B 505M 2025-12
Tandem Diabetes Care USD 282.09M 9.97M 2025-12
Teleflex USD 532.64M 3.29B 2025-12
Terumo JPY 252.74B 22.88B 2025-12
Thermo Fisher Scientific USD 9.91B 867M 2025-12
Zimmer Biomet Holdings USD 1.94B 277.8M 2025-12